Disparities in Reported Testing for 1p/19q Codeletion in Oligodendroglioma and Oligoastrocytoma Patients: An Analysis of the National Cancer Database
PurposeA chromosomal 1p/19q codeletion was included as a required diagnostic component of oligodendrogliomas in the 2016 World Health Organization (WHO) classification of central nervous system tumors. We sought to evaluate disparities in reported testing for 1p/19q codeletion among oligodendrogliom...
Guardado en:
Autores principales: | Jad Zreik, Panagiotis Kerezoudis, Mohammed Ali Alvi, Yagiz U. Yolcu, Sani H. Kizilbash |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f92be18a923439d93f50d77c72a2060 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oligodendroglioma anaplásico quístico: Reporte de caso
por: Illescas C.,Javier, et al.
Publicado: (2020) -
Case Report: Detection of Symptomatic Treatment-Related Changes in a Patient With Anaplastic Oligodendroglioma Using FET PET
por: Elena Katharina Bauer, et al.
Publicado: (2021) -
Gliomas de bajo grado: Viejas controversias, nuevas evidencias
por: Valenzuela M.,Raúl
Publicado: (2005) -
Persistent racial disparities in cervical cancer screening with Pap test
por: Cassidi C. McDaniel, et al.
Publicado: (2021) -
Development and Validation of an Efficient MRI Radiomics Signature for Improving the Predictive Performance of 1p/19q Co-Deletion in Lower-Grade Gliomas
por: Quang-Hien Kha, et al.
Publicado: (2021)